NABRIVA THERAPEUTICS PLC (NBRV) Stock Analyst Earnings Estimates
NASDAQ:NBRV - Nasdaq - IE000OZRGNV6 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.03M -46.94% | 28.895M 474.45% | 36.935M 27.82% | 72.189M 95.45% | 105.91M 46.71% | 136.58M 28.96% | 167.1M 22.35% | 191.91M 14.85% | |
| EBITDA YoY % growth | -65.7M 16.93% | -48.172M 26.68% | -50.956M -5.78% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -66.12M 16.82% | -48.528M 26.61% | -51.173M -5.45% | -31.805M 37.85% | -3.655M 88.51% | 15.898M 535.01% | 37.193M 133.95% | 56.563M 52.08% | |
| Operating Margin | -1,314.51% | -167.95% | -138.55% | -44.06% | -3.45% | 11.64% | 22.26% | 29.47% | |
| EPS YoY % growth | -147.75 47.23% | -27.03 81.71% | N/A 34.44% | -8.94 49.57% | -0.96 89.27% | 3.67 482.98% | 8.31 126.39% | 12.26 47.48% |
All data in USD
| Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|
| EPS Q2Q % growth | -2.35 47.87% | -1.99 52.76% | -1.36 65.98% |
| Revenue Q2Q % growth | 17.748M 93.10% | 18.768M 105.05% | 22.515M 112.99% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.185M 21.29% | -7.268M 35.12% | -5.132M 71.51% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | 31.25% | -3.44 | % | |
| Q4 2022 Q2Q % growth | 33.53% | -3.99 | % | |
| Q3 2022 Q2Q % growth | -4.21 -701.90% | -4.11 | -0.10 | -2.55% |
| Q2 2022 Q2Q % growth | -4.50 37.93% | -5.10 | 0.60 | 11.76% |
| Q1 2022 Q2Q % growth | -5.00 62.26% | -4.85 | -0.16 | -3.20% |
| Q4 2021 Q2Q % growth | -6.00 78.38% | -4.85 | -1.16 | -23.84% |
| Q3 2021 Q2Q % growth | -0.53 97.67% | -6.25 | 5.72 | 91.60% |
| Q2 2021 Q2Q % growth | -7.25 79.29% | -8.84 | 1.59 | 17.99% |
| Q1 2021 Q2Q % growth | -13.25 78.80% | -17.09 | 3.84 | 22.45% |
| Q4 2020 Q2Q % growth | -27.75 61.72% | -24.23 | -3.52 | -14.55% |
| Q3 2020 Q2Q % growth | -22.50 62.50% | -24.86 | 2.36 | 9.50% |
| Q2 2020 Q2Q % growth | -35.00 53.33% | -40.80 | 5.80 | 14.22% |
| Q1 2020 Q2Q % growth | -62.50 13.79% | -67.32 | 4.82 | 7.16% |
| Q4 2019 Q2Q % growth | -72.50 | -84.66 | 12.16 | 14.36% |
| Q3 2019 Q2Q % growth | -60.00 | -72.04 | 12.04 | 16.71% |
| Q2 2019 Q2Q % growth | -75.00 | -85.43 | 10.42 | 12.20% |
| Q1 2019 Q2Q % growth | -72.50 | -82.11 | 9.61 | 11.70% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | 7.59M -5.36% | 13.158M | -5.568M | -42.32% |
| Q4 2022 Q2Q % growth | 10.571M 14.15% | 11.258M | -687K | -6.10% |
| Q3 2022 Q2Q % growth | 9.153M 3.28% | 10.889M | -1.736M | -15.94% |
| Q2 2022 Q2Q % growth | 9.191M 11.50% | 8.701M | 490K | 5.63% |
| Q1 2022 Q2Q % growth | 8.02M 217.00% | 9.767M | -1.747M | -17.89% |
| Q4 2021 Q2Q % growth | 9.261M 276.46% | 10.301M | -1.04M | -10.10% |
| Q3 2021 Q2Q % growth | 8.862M 586.98% | 9.69M | -828K | -8.54% |
| Q2 2021 Q2Q % growth | 8.243M 1,582.24% | 6.105M | 2.138M | 35.02% |
| Q1 2021 Q2Q % growth | 2.53M 220.25% | 2.295M | 235K | 10.24% |
| Q4 2020 Q2Q % growth | 2.46M 645.45% | 615.57K | 1.844M | 299.63% |
| Q3 2020 Q2Q % growth | 1.29M -81.36% | 459K | 831K | 181.05% |
| Q2 2020 Q2Q % growth | 490K -7.55% | 408K | 82K | 20.10% |
| Q1 2020 Q2Q % growth | 790K -53.53% | 466.905K | 323.095K | 69.20% |
| Q4 2019 Q2Q % growth | 330K | 1.864M | -1.534M | -82.30% |
| Q3 2019 Q2Q % growth | 6.92M | 1.069M | 5.851M | 547.33% |
| Q2 2019 Q2Q % growth | 530K | 803.76K | -273.76K | -34.06% |
| Q1 2019 Q2Q % growth | 1.7M | 595.425K | 1.105M | 185.51% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |